City
Epaper

Long queue outside vaccination centres after Delhi commences inoculation for people b/w 18-44 years

By ANI | Published: May 03, 2021 11:14 AM

As Delhi starts vaccination for the beneficiaries between 18-44 years, the long queues can be seen outside various vaccination centres in the national capital.

Open in App

As Delhi starts vaccination for the beneficiaries between 18-44 years, the long queues can be seen outside various vaccination centres in the national capital.

Pre-registration is mandatory for beneficiaries in the 18-45 age group and there is no walk-in facility for this category.

"COVID vaccination is important citing the present situation. Vaccination can reduce the death tendency," said Shruti, a beneficiary waiting for his term to get vaccinated at a vaccination centre in Ashok Nagar area.

Another beneficiary Mithun toldthat he was waiting for long time for the government to open a window for the vaccination for the 18-45 age group.

"I am excited to get myself vaccinated against COVID-19. Vaccination is important as the cases in the country are rising," he added.

"I registered myself yesterday only and got the appointment today. This is good," Pavan, another beneficiary waiting to himself vaccinated said.

Delhi Chief Minister Arvind Kejriwal on Saturday had announced that the vaccination for the people aged between 18-44 years will be vaccinated from May 3 while the vaccination for the same was started across the country on May 1.

The country had started the COVID-19 vaccination drive on January 16 with two vaccines -- Covishield (Oxford-AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited).

As many as 77 government schools in the national capital are serving as COVID-19 vaccination centres for people between 18-44 years.

Delhi recorded 20,394 new COVID-19 cases and 407 deaths on Sunday.

As per the official data issued on Sunday, the total count of cases in the city has gone up to 11,94,946 including 92,290 active cases and 10,85,690 recoveries. The death toll has gone up to 16,966.

Meanwhile, the lockdown in the national capital has been extended till May 10.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat BiotechArvind KejriwalSerum Institute Of IndiaSerum institute of india pvt. ltdSerum india
Open in App

Related Stories

Social ViralCovishield Funny Memes Go Viral After AstraZeneca Admits Its COVID-19 Vaccine Can Cause Rare Side Effects

NationalBJP Leader Files Defamation Case Against CM Arvind Kejriwal, Atishi Before Delhi Court

NationalSunita Kejriwal, Atishi Meet Delhi CM Arvind Kejriwal in Tihar Jail

NationalDelhi Excise Policy Case: Why No Bail Plea in Trial Court, Supreme Court Asks CM Arvind Kejriwal

NationalDelhi CM Arvind Kejriwal’s Wife Sunita Given Permission To Meet Him in Tihar Jail, Says AAP

National Realted Stories

NationalSenior secondary schools in Haryana see 85.31 p.c. pass percentage

NationalBJP President Nadda holds roadshow in K’taka for ex-CM Basavaraj Bommai

NationalAmbedkar said there is no place for reservation based on religion, J.P. Nadda slams Cong at Intellectual Meet

NationalOdisha continues to reel under scorching heat wave conditions

NationalOver 66 p.c. voting in phase 1, 2 of Lok Sabha polls: Election Commission